Wegovy is approved for people with a: BMI of 30 or higher
In the study by Bohne et al., glucagon-like peptide-1 (GLP1) and GLP-1RA therapy in dB/dB mice reduced susceptibility to AF and duration of arrhythmia episodes
"It's a once-weekly injectable being studied for obesity and related metabolic conditions," adds Dr
The gradual dose escalation used in trials is clinically important it is designed to reduce the incidence and severity of nausea, vomiting, and other gastrointestinal adverse effects that are common with this class of medication
CrossRef Effects of metabolic syndrome on pulmonary infection in pediatric bronchial asthma: a narrative review Li He, Yang Ye Frontiers in Pediatrics .2026;[Epub] CrossRef Microbial metabolites at the nexus of gut-brain communication and neurodevelopmental disorders Yupeng Lai, Ming Zhang, Dandan Lang, Enfu Tao Frontiers in Nutrition .2026;[Epub] CrossRef Targeting the Human Gut MicrobiotaBetween Conventional Therapy and Precision Genetic Engineering Naomi-Adina Ciurea, Laura Mahdi, Annarita Graziani, Agostino Di Ciaula, Piero Portincasa, Mohamad Khalil Nutrients .2026
It supports your bodys natural processes, and like most internal supplements, it needs time and consistency to show visible benefits